Dr. Shune highlights that the growing availability of FDA-approved agents with distinct and complementary mechanisms has ...

From anxiety about job loss to data privacy, mental health workers, lawmakers and labor unions are trying to mitigate AI's ...

Plus500 reports a transformative investment landscape with AI, quantum computing, and clean tech showing significant growth, ...

Dr. Shune concludes the discussion by focusing on safety, sequencing, and practical considerations for incorporating ...

Guidelines emphasize single-pill combinations and deprescribing strategies to combat polypharmacy and hyperpolypharmacy in ...

A pregnancy announcement sparks debate about friendship expectations after one friend says the news exceeds her mental ...

The American Society of Plastic Surgeons said it found “insufficient evidence” that the benefits of chest, genital and facial ...

Are Warning Labels Misleading Patients? New Evidence Raises Questions In A Nutshell A massive analysis of more than 150,000 ...

In fact, the recent months have included some of the more significant achievements in Arrowhead's history. First, on November ...

Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...

Statins do not cause the majority of the conditions that have been listed in their package leaflets, including memory loss, ...